首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 22-((1H-吲哚-3-基)甲基)-31-(2-氨基-2-氧代乙基)-19,34-双(4-氨基丁基)-37-(2-(2-氨基丙酰胺基)乙酰胺基)-13,25,28-三苄基-10,16-双(1-羟基乙基)-7-(羟甲基)-6,9,12,15,18,21,24,27,30,33,36-十一氧代-1,2-二硫杂-5,8,11,14,17,20,23,26,29,32,35-十一氮杂环辛三十八烷-4-羧酸

22-((1H-吲哚-3-基)甲基)-31-(2-氨基-2-氧代乙基)-19,34-双(4-氨基丁基)-37-(2-(2-氨基丙酰胺基)乙酰胺基)-13,25,28-三苄基-10,16-双(1-羟基乙基)-7-(羟甲基)-6,9,12,15,18,21,24,27,30,33,36-十一氧代-1,2-二硫杂-5,8,11,14,17,20,23,26,29,32,35-十一氮杂环辛三十八烷-4-羧酸

22-((1H-indol-3-yl)methyl)-31-(2-amino-2-oxoethyl)-19,34-bis(4-aminobutyl)-37-(2-(2-aminopropanamido)acetamido)-13,25,28-tribenzyl-10,16-bis(1-hydroxyethyl)-7-(hydroxymethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontane-4-carboxylic acid

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

51110-01-1

中文名称

22-((1H-吲哚-3-基)甲基)-31-(2-氨基-2-氧代乙基)-19,34-双(4-氨基丁基)-37-(2-(2-氨基丙酰胺基)乙酰胺基)-13,25,28-三苄基-10,16-双(1-羟基乙基)-7-(羟甲基)-6,9,12,15,18,21,24,27,30,33,36-十一氧代-1,2-二硫杂-5,8,11,14,17,20,23,26,29,32,35-十一氮杂环辛三十八烷-4-羧酸

英文名称

22-((1H-indol-3-yl)methyl)-31-(2-amino-2-oxoethyl)-19,34-bis(4-aminobutyl)-37-(2-(2-aminopropanamido)acetamido)-13,25,28-tribenzyl-10,16-bis(1-hydroxyethyl)-7-(hydroxymethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontane-4-carboxylic acid

别名

AGCKNFFWKTFTSC (modifications: Disulfide bridge between 3 - 14) | AKOS015896026 | BCA11001 | SCHEMBL3046327 | SOMATOSTATIN | Stilamin | AGCKNFFWKTFTSC | Somatostain Acetate | FT-0630640 | L000577 | Panhibin | Somatostatin 14 | NHXLMOGPVYXJNR-UHFFFAOYSA-N

标准英文名

22-((1H-indol-3-yl)methyl)-31-(2-amino-2-oxoethyl)-19,34-bis(4-aminobutyl)-37-(2-(2-aminopropanamido)acetamido)-13,25,28-tribenzyl-10,16-bis(1-hydroxyethyl)-7-(hydroxymethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontane-4-carboxylic acid

MDL No.

MFCD00076762

分子式

C76H104N18O19S2

分子量

1637.91

精确分子量

1636.72

SMILES

CC(N)C(=O)NCC(=O)NC1CSSCC(C(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(C(C)O)NC(=O)C(CCCCN)NC(=O)C(CC2=CNC3=CC=CC=C23)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(N)=O)NC(=O)C(CCCCN)NC1=O

标准SMILES

CC(O)C1NC(=O)C(CCCCN)NC(=O)C(CC2=CNC3=CC=CC=C23)NC(=O)C(CC2C=CC=CC=2)NC(=O)C(CC2C=CC=CC=2)NC(=O)C(CC(N)=O)NC(=O)C(CCCCN)NC(=O)C(CSSCC(NC(=O)C(CO)NC(=O)C(NC(=O)C(CC2C=CC=CC=2)NC1=O)C(C)O)C(O)=O)NC(=O)CNC(=O)C(C)N

用途

Treatment of severe acute esophageal variceal bleeding; treatment of severe acute gastric or duodenal ulcer bleeding, or bleeding associated with acute erosive or hemorrhagic gastritis; prevention and treatment of acute pancreatitis and postoperative complications of pancreatic surgery; adjunctive therapy for pancreatic, biliary, and enteric fistulas; adjunctive treatment of diabetic ketoacidosis; management of acromegaly, gastrinoma, insulinoma, and vasoactive intestinal peptide-secreting tumors (VIPomas).

InChIKey

NHXLMOGPVYXJNR-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  51110-01-1 逆合成路线 1

—
—
ACXBIK027
51110-01-1
来源: SureRoute

2.  51110-01-1 逆合成路线 2

—
—
ACXBIK027
51110-01-1
来源: SureRoute

3.  51110-01-1 逆合成路线 3

—
—
ACXBIK027
51110-01-1
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手